Reaction
Hemiplegic Migraine reporting signals
As of the last recalculation, Hemiplegic Migraine appears in 326 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is EPTINEZUMAB-JJMR (PRR 102.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eptinezumab-Jjmr | 14 | 102.6 | 102.7 |
| Fremanezumab-Vfrm | 13 | 75.3 | 75.3 |
| Galcanezumab-Gnlm | 18 | 38.6 | 38.6 |
| Ivacaftor | 4 | 32.5 | 32.6 |
| Erenumab-Aooe | 23 | 28.6 | 28.6 |
| Rimegepant Sulfate | 4 | 20.4 | 20.4 |
| Esketamine Hydrochloride | 3 | 10.8 | 10.8 |